Oncogenic potential of Salmonella infection: a short review
DOI:
https://doi.org/10.60988/p.v37i2S.254Keywords:
Salmonella infection; colon cancer; gallbladder cancer; gut microbiome; toxin-antitoxin modulesAbstract
Salmonella infections, whether typhoidal or non-typhoidal, represent a major global health burden. While acute infections primarily manifest as gastroenteritis, chronic infections have been increasingly associated with severe long-term complications, including inflammatory bowel disease, gallbladder cancer, and colorectal cancer. Emerging evidence indicates that Salmonella infections may promote tumorigenesis through multiple mechanisms, such as chronic inflammation, DNA damage, and the manipulation of host cell signalling pathways. Specifically, Salmonella effector proteins, including AvrA, SopE, SopE2, and SopB, have been shown to play a critical role in activating oncogenic pathways such as Wnt/β-catenin, PI3K/Akt, and MAPK, which drive cellular transformation and tumour progression. Additionally, Salmonella infection can disrupt the gut microbiome, leading to dysbiosis, which may further contribute to cancer risk. Environmental factors, lifestyle choices, and genetic predispositions also modulate the risk of developing these cancers. This short review highlights the urgent need for further research in order to unravel the complex interactions between Salmonella infections, host factors, and cancer development, with the goal of improving prevention, early detection, and therapeutic strategies.
References
1. Gal-Mor O., Boyle E.C., Grassl G.A. Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ. Front. Microbiol. 5, 391, 2014. DOI: 10.3389/fmicb.2014.00391
2. Zha L., Garrett S., Sun J. Salmonella infection in chronic inflammation and gastrointestinal cancer. Diseases 7(1), 28, 2019. DOI: 10.3390/diseases7010028
3. van Elsland D.M., Duijster J.W., Zhang J., Stévenin V., Zhang Y., Zha L., et al. Repetitive non-typhoidal Salmonella exposure is an environmental risk factor for colon cancer and tumor growth. Cell Rep. Med. 3(12), 100852, 2022. DOI: 10.1016/j.xcrm.2022.100852
4. Cheng Y., Ling Z., Li L. The intestinal microbiota and colorectal cancer. Front. Immunol. 11, 615056, 2020. DOI: 10.3389/fimmu.2020.615056
5. Scanu T., Spaapen R.M., Bakker J.M., Pratap C.B., Wu L.E., Hofland I., et al. Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma. Cell Host Microbe 17(6), 763–774, 2015. DOI: 10.1016/j.chom.2015.05.002
6. Jiao Y., Zhang Y.G., Lin Z., Lu R., Xia Y., Meng C., et al. Salmonella Enteritidis effector AvrA suppresses autophagy by reducing Beclin-1 protein. Front. Immunol. 11, 686, 2020. DOI: 10.3389/fimmu.2020.00686
7. Stender S., Friebel A., Linder S., Rohde M., Mirold S., Hardt W.D. Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol. Microbiol. 36(6), 1206–1221, 2000. DOI: 10.1046/j.1365-2958.2000.01933.x
8. He Y., Wang J., Zhang R., Chen L., Zhang H., Qi X., et al. Epidemiology of foodborne diseases caused by Salmonella in Zhejiang Province, China, between 2010 and 2021. Front. Public Health 11, 1127925, 2023. DOI: 10.3389/fpubh.2023.1127925
9. Sun J. Impact of bacterial infection and intestinal microbiome on colorectal cancer development. Chin. Med. J. (Engl.) 135(4), 400–408, 2022. DOI: 10.1097/CM9.0000000000001979
10. McDowell R., Perrott S., Murchie P., Cardwell C., Hughes C., Samuel L. Oral antibiotic use and early-onset colorectal cancer: findings from a case-control study using a national clinical database. Br. J. Cancer 126(6), 957–967, 2022. DOI: 10.1038/s41416-021-01665-7
